CXCR4 and neoplasm: Investigating the largest cohort of patients with solid cancers imaged with [68 Ga]Ga-pentixafor PET/CT to date, CXCR4-positive tumor burden was identified in more than two-thirds of the patients, along with high image contrast indicative for good read-out capabilities.